PTCT - Citi lowers PTC Therapeutics to neutral amid uncertainty for DMD drug
2023-09-18 16:38:46 ET
More on PTC Therapeutics
- Seeking Alpha’s Quant Rating on PTC Therapeutics
- Historical earnings data for PTC Therapeutics
- Financial information for PTC Therapeutics
- PTC Therapeutics: Struggling Still But Potential Remains
- PTC Therapeutics, Inc. ( PTCT ) Q2 2023 Earnings Call Transcript
- Larimar, Design higher as they benefit from Biogen deal for Reata
- PTC wins EU backing to expand label for SMA drug Evrysdi
For further details see:
Citi lowers PTC Therapeutics to neutral amid uncertainty for DMD drug